Clinical Trial Update: Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin [Phase 1]

View source ↗

Summary

Phase 1 study update on subcutaneous doses of HIP2B in adults with type 2 diabetes mellitus treated with metformin; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HIP2B (HIP2B)

Snippet

Sponsor: CureDM | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED